Fabian Dey

This inventor holds 28 USPTO granted patents and 29 published patent applications and 22 EPO patents, primarily in Medicinal Chemistry. Top assignees: Hoffmann-La Roche Inc., C4 Therapeutics, Inc., Alkermes, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabian Dey. Retrieved from https://idiyas.com/inventor/fabian-dey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 29)

% Patents Active = 96.4

EPO Patents = 22 (Patent Applications = 45)

Average Co-Inventor Count = 5.3

ph-index = 6

Forward Citations = 60(Granted Patents)

Location History:

Basal, CH (2023)
Basel, CH (2018 - 2024)

Company Filing History:

13 out of 5,024

Hoffmann-La Roche Inc.

patents

10 out of 40

C4 Therapeutics, Inc.

Rodin Therapeutics, Inc.

patents

5. 1 out of 1

C4 Therepeutics, Inc.

patent

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Spirocyclic Compounds

Heterocyclic Compounds

Autoimmune Disease

Dihydrobenzimidazolones

Histone Deacetylase Inhibitors

Pyrazolopyridine Compounds

Bacterial Infections

Glutarimides

Peptide Macrocycles

Cyclic Amidine Compounds

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662488 - Spirocyclic compounds (2026-06-23),

2. 12528797 - Heterocyclic compounds for medical treatment (2026-01-20),

3. 12503471 - Triazatricycle compounds for the treatment of autoimmune disease (2025-12-23),

4. 12486273 - Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune disease (2025-12-02),

5. 12421229 - Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease (2025-09-23),

6. 12365681 - Dihydrobenzimidazolones for medical treatment (2025-07-22),

7. 12252484 - Pyrazolopyridine compounds for the treatment of autoimmune disease (2025-03-18),

8. 12227504 - Spirocyclic compounds (2025-02-18),

9. 12157746 - Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune disease (2024-12-03),

10. 12091397 - Dihydroquinolinones for medical treatment (2024-09-17),

11. 11952363 - Piperazine compounds for the treatment of autoimmune disease (2024-04-09),

12. 11858939 - Hetero-halo inhibitors of histone deacetylase (2024-01-02),

13. 11802131 - Glutarimides for medical treatment (2023-10-31),

14. 11787802 - Dihydrobenzimidazolones for medical treatment (2023-10-17),

15. 11713327 - Heteroaryl heterocyclyl compounds for the treatment of autoimmune disease (2023-08-01),

Title: The Innovative Mind of Fabian Dey

Introduction: Fabian Dey, a visionary inventor hailing from Basel, Switzerland, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Fabian Dey's recent patents include cutting-edge advancements in renewable energy storage systems and artificial intelligence algorithms for autonomous vehicles.

Career Highlights: With a career spanning over two decades, Fabian Dey has established himself as a pioneer in the tech industry, leading research teams and spearheading projects that have revolutionized various sectors.

Collaborations: Throughout his career, Fabian Dey has collaborated with top research institutions, leading companies, and brilliant minds from around the globe, fostering a culture of innovation and excellence.

Conclusion: Fabian Dey's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors and shape the future of technological advancements.

Profile summary based on public USPTO records.